Chinese | Asia-Pacific Research | America Research | European Research
Home » Category » Grunenthal GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Grunenthal GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Date: 2015-07
Pages:47
Price:
Need Help

“Summary

Grunenthal GmbH (Grunenthal) is an international research-based pharmaceutical company. It holds expertise in the therapeutic area of pain. The company researches, develops, produces and markets a wide range of products for the treatment of pain and innovative formulations for established active substances.. Some of the company鈥檚 key products include Versatis, Zaldiar, Palexia, Transtec, Tramal, Norspan, Recivit and Tapentadol, among others. It also develops solutions for the improved management of chronic pain. Grunenthal is the research-oriented pharmaceutical company with major investments in research and development. It markets its products in more than 155 countries and operates through its affiliates in 25 countries. Grunenthal is headquartered in Aachen, Germany.

The company focuses on becoming the patient-centric company in the field of pain and be a leader in therapy innovation. It plans to increase its engagement and investments in the development of new products. In line with this the company entered into a commercial collaboration agreement with AcelRx Pharmaceuticals, Inc., for the European Union commercialization of AcelRx’s ZALVISO.

Grunenthal GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company鈥檚 (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company鈥檚 operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.”

MORE PUBLICATIONS

Categories

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample
Copyright © 2014, All Rights Reserved, GosReports.com   Sitemap